NYU Langone Researchers Tested AI Breast Cancer Tool
A new artificial intelligence model predicted five-year breast cancer risk by analyzing patterns in historical mammograms.
Updated on Oct. 11, 2026 in Cancer
Live Poll
Would you trust an AI tool to help determine your personal cancer screening schedule?
Researchers at NYU Langone Health have tested an artificial intelligence tool designed to estimate a patient's risk of developing breast cancer within five years. The technology functions by tracking subtle changes in breast tissue over time through 3D imaging.
Why it matters
The model aims to improve early detection by identifying high-risk patients who might not be flagged by traditional screening methods like family history assessments. By recognizing patterns invisible to the human eye, the tool could lead to more personalized preventative care.
The AI model was developed using a dataset of 313,000 mammograms from 161,000 women. It is designed to provide risk assessments spanning a five-year period.
The players
NYU Langone Health
This academic medical center located in New York City operates multiple research facilities, including the Perlmutter Cancer Center.
The details
The tool evaluates 3D mammograms to detect evolving tissue characteristics that precede cancer development. Unlike standard assessments that rely on biographical data such as family history, this system utilizes digital image analysis to identify biological markers of risk.
Timeline
October 11, 2026: The study was published in the American Journal of Roentgenology.
Health Landscape
This research at the Perlmutter Cancer Center represents a broader trend in oncology toward integrating machine learning into diagnostic radiology. It follows a shift in the field to move beyond traditional risk factors toward predictive modeling based on longitudinal imaging data.
Because the model is not currently FDA-authorized, it is not yet available for routine diagnostic use in clinics. Patients should continue to follow established screening guidelines recommended by their healthcare providers while researchers work to validate the tool across different hospital systems.
The takeaway
This technology highlights how artificial intelligence can eventually provide more precise risk stratification for patients undergoing routine imaging. Future research will need to demonstrate the model's accuracy across diverse hardware systems and patient populations before it can be implemented in clinical settings.
Further reading
For more information on current screening innovations, visit the Cancer section.
Live Poll
Would you trust an AI tool to help determine your personal cancer screening schedule?
